CHET Primary Faculty
Darlingtina K. Esiaka, PhD, CPG, CPH
Dr. Darlingtina Esiaka, CPG, CPH, has a dual-title PhD in Social Psychology and Gerontology from the University of Kansas, a master’s in psychology from Arkansas Tech University with Distinction, Graduate certificates in Health Psychology and African Studies from the University of Kansas, a Bachelor of Science in Psychology with First class honors and a Diploma in Social Works from the University of Nigeria, Nsukka. Her research interests revolve around two major themes. One focuses on the early detection of Alzheimer's disease and related dementias (ADRD) in aging Black communities. She examines how to detect progression and conversion to ADRD, long before the presentation of behavioral symptoms. The second focuses on the early detection of cancer in older Black men. She investigates psychosocial factors that predict fatal stage cancer diagnosis and survivorship in older Black men.
She has received over 20 awards and recognitions, including the Emily Taylor Center for Women & Gender Equity – Kathleen McCluskey-Fawcett Woman Mentoring Women award, the Gerontological Society of America (GSA)'s Career Development and Junior Investigator Diversity Fellow Award. Her work has been supported by federal and private funders such as NIA, New Jersey Health Foundation, and Alzheimer’s Association.
Carolyn Lauckner, PhD
Dr. Carolyn Lauckner is currently an associate professor in the department of behavioral science and the Center for Health, Engagement, and Transformation (CHET). She is also co-director of the mHealth Application Modernization and Mobilization Alliance and associate director of the Food as Health Alliance. Her research is focused on behavioral interventions that utilize modern communication technologies to encourage the adoption of healthy behaviors, with a focus on substance and alcohol use among vulnerable populations. She is currently mPI on an NCI-funded R21 aiming to reduce alcohol use among adolescent and young adult cancer survivors through an mHealth intervention and mPI on a NIAAA-funded R01 testing an innovative app-based alcohol reduction intervention for young adult sexual minority men and transgender individuals. Her work combines phone-based motivational interviewing, ecological momentary assessments, customized smartphone apps, Bluetooth breathalyzers, and home-based HIV/STI testing, all in an effort to provide fully remote behavioral interventions.
Erica Littlejohn, PhD
Dr. Erica Littlejohn is an assistant professor in the department of behavioral science, the Center for Health Engagement, and Transformation, and has affiliations in the Sanders-Brown Center on Aging and Spinal Cord and Brain Injury Research Center. Her overarching goal is to reduce the burden of neurological disease experienced by marginalized populations by elucidating the pathways and neurobiological mechanisms that drive neuropathology. Through her experience as a basic science researcher and expertise in neurological disease health inequities, she aims to develop a translational research program to advance health equity research and undergird future health disparities interventions. Her current research specifically centers on investigating the role of social determinants of health (SDOH) and adverse childhood experience (ACE) exposure in mediating the risk and progression of cognitive impairment and decline in older adults. As part of her pre-clinical neuro-equity research foci, she examines the impact of ACE exposure and SDOH in multiple models of cognitive impairment, including traumatic brain injury (TBI), vascular cognitive impairment, and Alzheimer’s disease and related dementias (ADRD). Erica was previously an AAAS Fellow within the NIH National Institute of Neurological Disorders and Stroke (NINDS) Office of Global Health and Health Disparities (OGHHD) in the Division of Clinical Research. Along with renowned experts, Dr. Littlejohn was a part of the team that developed the NINDS Social Determinants of Health Framework as a part of the NINDS health equity strategic planning. She also completed a postdoctoral fellowship at the University of Texas, Health Science Center at San Antonio, as an NIH T32 training grant fellow in Pathobiology of Occlusive Vascular Disease. She investigated the electrophysiological function of GABAergic vagal neurons in the brainstem and its central regulation of peripheral metabolism and cardiovascular health. Prior to her fellowship and postdoc positions, Dr. Littlejohn completed her PhD at the University of Kentucky (UK) where she investigated cellular and molecular mechanisms underlying post-traumatic neural plasticity. During her predoctoral training she served as the President of the UK Black Graduate and Professional Student Association (UKBGPSA) and led the organization of the 2016 UKBGPSA: Call to Action Town Hall event. She was the recipient of the University of Kentucky Shane Carlin & Annie Sit Inclusion Award (2016) and the Kentucky Multicultural Opportunities, Strategies, and Institutional Inclusiveness Consortium (MOSAIIC) Award (2016).
Delvon Mattingly, PhD
Dr. Mattingly is a primary faculty member of the Center for Health, Engagement, and Transformation and an assistant professor (non-tenure track) in the department of behavioral science in the College of Medicine. He is also a member of the Markey Cancer Center Prevention and Control Program, the Substance Use Priority Research Area, and the UNITE Research Priority Area. Dr. Mattingly is a social epidemiologist whose research examines the psychosocial, policy, and structural determinants of community and population health, as well as associated disparities. He has extensive training in descriptive and analytical epidemiological methods, as well as tobacco and cannabis control and regulatory science. He received the majority of his research training through two NIH/FDA-funded Tobacco Centers of Regulatory Science (TCORS): the American Heart Association Tobacco Regulation and Addiction Center (A-TRAC) (TCORS 1.0) and the University of Michigan and Georgetown University’s Center for the Assessment of Tobacco Regulations (CAsToR) (TCORS 2.0). He now collaborates with the Appalachian Tobacco Regulatory Science Team (AppalTRUST), University of Kentucky’s new TCORS 3.0 center. Dr. Mattingly’s research applies a social epidemiological perspective to addressing health disparities in substance use, addiction, and cancer risk and survival. He has authored over 50 publications in peer-reviewed journals and currently leads multiple funded research studies, including a National Cancer Institute Supplement grant examining the impact of local flavored tobacco control policies on disparities in flavored e-cigarette use among young adults.
Laurie McLouth, PhD
Dr. McLouth joined the faculty of the UK College of Medicine Department of Behavioral Science and Center for Health Engagement, and Transformation in 2019. She is a clinical psychologist with expertise in cancer survivorship, multilevel interventions, palliative care, and implementation science. Dr. McLouth has received numerous national awards, including recently being one of 11 investigators across the nation named an NCI Cancer Moonshot Scholar.
Dr. McLouth’s program of research focuses on developing and testing interventions to improve quality of life and quality of cancer care for patients and their caregivers facing advanced cancer, particularly in rural and socioeconomically disadvantaged areas. She is a behavioral researcher with expertise and research interests that include: (1) conducting quantitative and qualitative research to understand the impact of new cancer treatments on patients and their families; (2) developing and evaluating supportive care and survivorship care interventions that leverage positive psychology; and (3) identifying multi-level intervention targets to improve cancer care delivery and increase access to guideline-concordant cancer care. She is currently PI of an NCI-funded R01 to test the efficacy of a brief, hope-enhancing intervention for patients with advanced lung cancer, PI of an NCATS-funded KL2 piloting a multilevel intervention to integrate palliative care into advanced lung cancer, MPI on an NCI-funded R21 piloting an mhealth intervention to reduce alcohol use among posttreatment adolescent and young adult cancer survivors, and co-Investigator on several multiyear grants in cancer survivorship and cancer care delivery.
Justin Moore, PhD, MPH
Dr. Moore serves as an associate professor within the Center for Health Engagement, and Transformation (CHET) at the University of Kentucky College of Medicine, with roles as assistant director of population science within the department of internal medicine, and assistant director of community impact at the Markey Cancer Center. Previously, he worked as an assistant professor within the Cancer Prevention Control and Population Health Program at the Georgia Cancer Center, Augusta University. Dr. Moore is an epidemiologist with vast skills in biostatistics, database design, geographic information systems (GIS), mediation analysis, Bayesian methods, and cancer prevention and control. Dr. Moore’s research explores the intersection between social identity (race and/or sexual orientation and gender identity), place, chronic physiologic stress (allostatic load), and gene interactions on cancer health outcomes. Dr. Moore’s work delineated that place matters for African American, Hispanic, and rural populations characterized by hot spots of excess mortality from breast cancer, lung cancer, early-onset colorectal cancer, sepsis, and COVID-19. Dr. Moore’s current research interests lie in understanding the effects of race and place on determinants of breast cancer including breast cancer screening, mammographic density, life-course stress (allostatic load), and DNA methylation. Dr. Moore has published over 80 peer-reviewed, 40+ of these articles feature Dr. Moore as the lead or corresponding author. Dr. Moore publishes in journals such as JAMA, Cancer Epidemiology, Critical Care, The Journal of Clinical and Translational Sciences, and many others. In 2022, Dr. Moore won the American Association for Cancer Research, Minority in Cancer Research Faculty Award in recognition of his work and service.
Elizabeth Rhodus, PhD, MS, OTR/L
Dr. Elizabeth Rhodus, an assistant professor in the department of behavioral science and Sanders-Brown Center on Aging, and primary faculty of the Center for Health, Engagement, and Transformation in the College of Medicine at the University of Kentucky, has developed a research program based on clinical experiences as an occupational therapist with patients across the lifespan, during which she recognized the influence of the environmental supports on behaviors of those with cognitive impairment. However, a lack of robust assessment and evidence-based interventions focused on the relationship between person and environment undermines rigorous and effective clinical decision making. This gap and the substantial need in clinical care fueled her career shift to scholarship. Her research training has been framed with a strong theoretical understanding of aging with a PhD in gerontology and training in clinical trial design as a post-doctoral scholar at the University of Kentucky’s Alzheimer’s Disease Research Center funded by the NIH/NIA T32. Her career has additionally focused on clinical, service-oriented support, and research in areas throughout rural Appalachia including hospital-based care, home health, and skilled nursing facilities. These experiences exemplified health challenges which plague rural residents. Dr. Rhodus’ long-term career goal is to develop patient-oriented behavioral interventions which will promote healthy aging and quality of life for older adults.
Shyanika W. Rose, PhD, MA
Dr. Rose is a faculty member of the Center for Health Engagement, and Transformation (CHET) and an associate professor in the Department of Behavioral Science in the College of Medicine. She is also a member of the cancer prevention program of the Markey Cancer Center. Dr. Rose’s research focuses on policy approaches to reducing disparities in tobacco use, and her interests include point of sale marketing, advertising, distribution in neighborhoods, initiation of tobacco use, the amount of tobacco products used by individuals, and the challenges associated with quitting. Dr. Rose has published over 70 publications in peer-reviewed journals and is currently the principal investigator on a National Cancer Institute grant examining the implications of local flavored tobacco sales restrictions for groups experiencing tobacco-related health disparities. She is also lead of a project in the new AppalTRUST Tobacco Center of Regulatory Science. As a faculty member of CHET, she plans to continue her tobacco control research while also applying her skills in public policy and evaluation to other issues affecting health disparities, particularly marketing strategies in the food, alcohol, and cannabis industries that negatively impact the health of marginalized groups.
Selected Publications:
Perceived racial/ethnic discrimination, marketing, and substance use among young adults.